North America Myopia Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Type (High Myopia, Degenerative Myopia, and Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), and End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers)

No. of Pages: 109    |    Report Code: BMIRE00030510    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Myopia Treatment Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Myopia Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Myopia Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Demand for Myopia Treatment Products due to Increase in Prevalence
5.2 Market Opportunities
  • 5.2.1 Increased Awareness of Myopia Treatment
5.3 Future Trends
  • 5.3.1 Significant Opportunities in Developing Regions
5.4 Impact of Drivers and Restraints

6. North America Myopia Treatment Market Regional Analysis

6.1 North America Myopia Treatment Market Overview
6.2 North America Myopia Treatment Market Revenue 2020-2030 (US$ Million)
6.3 North America Myopia Treatment Market Forecast Analysis

7. North America Myopia Treatment Market Analysis – by Type

7.1 High Myopia
  • 7.1.1 Overview
  • 7.1.2 High Myopia: North America Myopia Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Degenerative Myopia
  • 7.2.1 Overview
  • 7.2.2 Degenerative Myopia: North America Myopia Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Progressive Myopia
  • 7.3.1 Overview
  • 7.3.2 Progressive Myopia: North America Myopia Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Myopia Treatment Market Analysis – by Treatment

8.1 Low-Dose Atropine Eye Drops
  • 8.1.1 Overview
  • 8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Contact Lenses
  • 8.2.1 Overview
  • 8.2.2 Contact Lenses: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Ortho-K
  • 8.3.1 Overview
  • 8.3.2 Ortho-K: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Refractive Surgery
  • 8.4.1 Overview
  • 8.4.2 Refractive Surgery: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Myopia Treatment Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Refractive Surgery: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Specialty Clinics
  • 9.2.1 Overview
  • 9.2.2 Refractive Surgery: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Refractive Surgery Centers
  • 9.3.1 Overview
  • 9.3.2 Refractive Surgery: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Myopia Treatment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Myopia Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Myopia Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Myopia Treatment Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Myopia Treatment Market Breakdown, by Treatment
    • 10.1.1.1.3 US: North America Myopia Treatment Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Myopia Treatment Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Myopia Treatment Market Breakdown, by Treatment
    • 10.1.1.2.3 Canada: North America Myopia Treatment Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Myopia Treatment Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Myopia Treatment Market Breakdown, by Treatment
    • 10.1.1.3.3 Mexico : North America Myopia Treatment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Myopia Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bausch Health Companies Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Alcon AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 CooperVision Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Topcon Healthcare Solutions Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ziemer Ophthalmic Systems AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Nidek Co Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Eyes Vision SL
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Haag-Streit AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Carl Zeiss AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

1. Bausch Health Companies Inc 
2. Alcon AG 
3. CooperVision Inc 
4. Johnson & Johnson Vision Care Inc 
5. Topcon Healthcare Solutions Inc 
6. Ziemer Ophthalmic Systems AG 
7. Nidek Co Ltd 
8. Eyes Vision SL 
9. Haag-Streit AG 
10. Carl Zeiss AG